Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Multiple myeloma highlights from EHA 2016

Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Paul Richardson, Prof Philip...

Multiple myeloma highlights from EHA 2016 ( Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Paul Richardson, Prof Philip McCarthy )

Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia

Dr Charles De Bock - KU Leuven, Leuven, Belgium

Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia ( Dr Charles De Bock - KU Leuven, Leuven, Belgium )

SL401 in patients with rare neoplasm

Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center...

SL401 in patients with rare neoplasm ( Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center, Houston, United States )

RNA regulation of JAK-STAT pathways in CML

Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA

RNA regulation of JAK-STAT pathways in CML ( Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA )

Daratumumab shows remarkable benefit in relapsed or refractory MM

Prof Meletios Dimopoulos - University Athens School of Medicine, Athens, Greece

$Daratumumab shows remarkable benefit in relapsed or refractory MM ( Prof Meletios Dimopoulos - University Athens School of Medicine, Athens, Greece )$

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence

Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence ( Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany )

Blinatumomab improves survival in ALL patients

Prof Max Topp - University of Würzburg, Würzburg, Germany

Blinatumomab improves survival in ALL patients ( Prof Max Topp - University of Würzburg, Würzburg, Germany )

Stopping tyrosine kinase inhibitors in CML

Dr Johan Richter - Lund University, Sweden

Stopping tyrosine kinase inhibitors in CML ( Dr Johan Richter - Lund University, Sweden )

Evaluation of ibrutinib in treatment of CLL with 17p deletion

Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA

Evaluation of ibrutinib in treatment of CLL with 17p deletion ( Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA )

Nivolumab restores effective anti-tumour response in Hodgkin lymphoma

Dr Anas Younes - Memorial Sloan Kettering Cancer Centre, New York, USA

Nivolumab restores effective anti-tumour response in Hodgkin lymphoma ( Dr Anas Younes - Memorial Sloan Kettering Cancer Centre, New York, USA )

An overview of MCL from EHA 2016

Professor Simon Rule and Professor Steven Le Gouill

An overview of MCL from EHA 2016 ( Professor Simon Rule and Professor Steven Le Gouill )

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate...

Dr Goran Ahlgren - Lund University, Malmö, Sweden

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer ( Dr Goran Ahlgren - Lund University, Malmö, Sweden )

More from ecancer